HOME >> BIOLOGY >> NEWS
Canada's new government launches ecoEnergy technology initiative

This press release is also available in French.

OTTAWA -- The Honourable Gary Lunn, Minister of Natural Resources, and the Honourable John Baird, Minister of the Environment, today announced the ecoEnergy Technology Initiative--a $230-million investment in the research, development and demonstration of clean-energy technologies.

"Canada is an emerging energy superpower," said Minister Lunn. "But our real challenge is to be a clean-energy superpower. To do this, we must address the fact that the greatest source of untapped energy is the energy we waste. We must also increase our use of renewable energy and develop the science and technology to make conventional energy cleaner."

"As part of our environmental agenda, Canada's New Government is introducing this important initiative to protect Canadians' top priority--the environment--while building a competitive and sustainable economy," said Minister Baird.

While Canada's Clean Air Act forms the backbone of the government's environmental plan, the ecoEnergy Technology Initiative will foster the next generation of clean technologies to break through to emissions-free energy production and energy use.

The $230-million ecoEnergy Technology Initiative will accelerate the development and market-readiness of technology solutions in clean energy. It will ensure that Canadians and future generations have clean air, water, land and energy. This is real change for real results.

"Canada's New Government encourages industry and the provinces to further invest in science and technology to deliver real results for the production of clean energy," said Minister Lunn.

The new Initiative is a focused, integrated approach built on key priorities that include carbon dioxide sequestration, clean coal, clean oil sands production and renewable energy. Priorities will be further develope
'"/>

Contact: Ghyslain Charron
media@nrcan.gc.ca
613-992-4447
Natural Resources Canada
17-Jan-2007


Page: 1 2

Related biology news :

1. Canadas new government invests $200M in the fight against the mountain pine beetle
2. Report highlights change in Canadas forests
3. Report: Canadas Yellowstone too small for wildlife
4. Creating new insight into HIV-AIDS virus wins Canadas top student biotech prize
5. Workshop: Canadas Leadership in International Innovation
6. Mount Sinai Hospital researcher develops Canadas first embryonic stem cell lines
7. Queens biologist awarded Canadas top science prize
8. Arctic mystery no longer: Dinosaurs walked Canadas great north
9. Nanotech safety needs specific government risk research strategy and funding
10. NJIT computer scientist audits government, hospital terms seeking errors
11. US government $20M NIAID grant funds Proteome Systems catalytic scavenger compounds

Post Your Comments:
(Date:12/11/2014)... , Dec. 09, 2014 Research and Markets ... ( http://www.researchandmarkets.com/research/9ql3kr/biometrics_market ) has announced ... India 2015-2019" report to their offering. ... market is the adoption of multimodal biometric systems. ... of an individual for verification and identification purposes. ...
(Date:12/10/2014)... Forest Baptist Medical Center today announced plans for a ... Funding for this $50 million capital project is part ... launched next summer. The medical education ... R.J. Reynolds Tobacco Company complex, adjacent to 525@vine in ... plans to be ready to welcome medical students in ...
(Date:12/5/2014)... Dec. 4, 2014  Tute Genomics, a leader in ... in Series A1 funding led by UK-based Eurovestech. Peak ... in the investment round. "We are at ... adopts next-generation sequencing and seeks new approaches for the ... Robison , MD MBA, and CEO of Tute Genomics. ...
Breaking Biology News(10 mins):Biometrics Market in India 2015-2019: Key Vendors are 3M Cogent, NEC, Safran and Suprema 2Wake Forest Baptist to Build New Medical Education Facility In Wake Forest Innovation Quarter 2Wake Forest Baptist to Build New Medical Education Facility In Wake Forest Innovation Quarter 3Wake Forest Baptist to Build New Medical Education Facility In Wake Forest Innovation Quarter 4Tute Genomics Raises $2.3 Million to Scale Up Cloud-Based Genome Analytics and Accelerate Personalized Medicine 2Tute Genomics Raises $2.3 Million to Scale Up Cloud-Based Genome Analytics and Accelerate Personalized Medicine 3
(Date:12/19/2014)... Dec. 18, 2014 Relmada Therapeutics, Inc. (OTCQB: ... treatment of chronic pain, announced the results of its ... "This was a transformational year in Relmada,s history and ... our company," said Sergio Traversa , chief executive ... executed on key financial, human resource and clinical development ...
(Date:12/17/2014)... 17, 2014 Ipsen Biopharmaceuticals, Inc., ... ADR: IPSEY), today announced that Somatuline® ... Somatuline®) was approved by the U.S. Food and ... neuroendocrine tumors (GEP-NETs) in adult patients with unresectable, ... disease to improve progression-free survival (PFS). , “The ...
(Date:12/17/2014)... CA (PRWEB) December 17, 2014 Audacity, ... activation agency and member of the Huntsworth Health Group, ... to its executive team. In her role, Gonzales will ... , “We are incredibly honored to welcome a talent ... Chief and CEO, Gaëtan Fraikin. “She is a proven ...
(Date:12/17/2014)... Mass. , Dec. 17, 2014   Synageva ... biopharmaceutical company developing therapeutic products for rare disorders, announced ... Conference being held in San Francisco, CA. ... President and Chief Executive Officer, will present on Monday, ... EST).  The presentation will be webcast live and may ...
Breaking Biology Technology:Relmada Therapeutics Announces Results of Annual Shareholders Meeting 2Ipsen Announces the FDA Approval of Somatuline® Depot® (lanreotide) Injection for the Treatment of Gastroenteropancreatic Neuroendocrine Tumors 2Ipsen Announces the FDA Approval of Somatuline® Depot® (lanreotide) Injection for the Treatment of Gastroenteropancreatic Neuroendocrine Tumors 3Ipsen Announces the FDA Approval of Somatuline® Depot® (lanreotide) Injection for the Treatment of Gastroenteropancreatic Neuroendocrine Tumors 4Ipsen Announces the FDA Approval of Somatuline® Depot® (lanreotide) Injection for the Treatment of Gastroenteropancreatic Neuroendocrine Tumors 5Ipsen Announces the FDA Approval of Somatuline® Depot® (lanreotide) Injection for the Treatment of Gastroenteropancreatic Neuroendocrine Tumors 6Ipsen Announces the FDA Approval of Somatuline® Depot® (lanreotide) Injection for the Treatment of Gastroenteropancreatic Neuroendocrine Tumors 7Ipsen Announces the FDA Approval of Somatuline® Depot® (lanreotide) Injection for the Treatment of Gastroenteropancreatic Neuroendocrine Tumors 8Audacity Welcomes Healthcare Communications Expert Jamie Gonzales as Senior Vice President of Client Services 2
Cached News: